Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Self-emulsified THC/CBD Powder vs Oil
NCT06149988Phase 1Unknown
- Sponsor
- CapSoil Technologies
- Start
- Aug 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of dronabinol and cannabidiol (2 arms), sponsored by CapSoil Technologies. Primary endpoints: Maximum Plasma Concentration at 30 days, Area Under the Curve at 30 days and 2 more. Status: unknown.
02
Drugs
dronabinolcannabidiol
Beyond the preview
Go deeper on NCT06149988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06149988.